Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marla J. Brickman"'
Autor:
Zhixiao Wang, Kenneth A. Kern, E. Claire Dees, Sherry Li, Stephen D. Myers, Jolanda Paolini, Paul J. Healey, Marla J. Brickman, Dennis L. Citrin, Denise A. Yardley
Publikováno v:
Breast Cancer Research and Treatment. 136:759-767
This multicenter, open-label phase II study was conducted to evaluate sunitinib monotherapy in patients with either metastatic or locoregionally recurrent advanced breast cancer. Patients received sunitinib 37.5 mg on a continuous daily dosing schedu
Autor:
Lynne Pauer, Kenneth A. Getz, Briggs W. Morrison, Marc Wilenzick, Diane Simmons, Zachary P. Hallinan, Zhanna Jumadilova, Marla J. Brickman
Publikováno v:
Expert Review of Clinical Pharmacology. 5:149-156
Although the overwhelming majority of study volunteers want to receive information on the results of their participation in clinical trials, research suggests that most study volunteers never do. CISCRP - an independent nonprofit organization - in co
Autor:
Kenjiro Aogi, Soo-Chin Lee, Mei-Ching Liu, Miguel Martin, Jean-Marc Ferrero, Laurence Vanlemmens, Hiroji Iwata, Toshio Tabei, Carlos H. Barrios, Kenneth A. Kern, Nadia Harbeck, Ke-Ke Zhang, Marla J. Brickman, Roberto Lugo-Quintana, Xavier Pivot
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2010, 121 (1), pp.121-31. ⟨10.1007/s10549-010-0788-0⟩
Breast Cancer Research and Treatment, Springer Verlag, 2010, 121 (1), pp.121-31. ⟨10.1007/s10549-010-0788-0⟩
Breast Cancer Research and Treatment, 2010, 121 (1), pp.121-31. ⟨10.1007/s10549-010-0788-0⟩
Breast Cancer Research and Treatment, Springer Verlag, 2010, 121 (1), pp.121-31. ⟨10.1007/s10549-010-0788-0⟩
International audience; This multicenter, randomized, open-label phase III trial (planned enrollment: 700 patients) was conducted to test the hypothesis that single-agent sunitinib improves progression-free survival (PFS) compared with capecitabine a
Publikováno v:
Molecular and Biochemical Parasitology. 74:167-178
We have used pulse-chase immunoprecipitations methods to study early post-translational processing of CBI-gp, a lysosomal membrane glycoprotein expressed by African trypanosomes, Rap67, a polyclonal antibody to CBI-gp, immunoprecipitated a 100-kDa gl
Autor:
J-M Ferrero, Kenjiro Aogi, Laurence Vanlemmens, SJ Lee, Marla J. Brickman, T. Tabei, Kenneth A. Kern, K. Zhang, H. Iwata, MC Liu, Carlos H. Barrios, Xavier Pivot, Miguel Martín
Publikováno v:
Cancer Research. 69:46-46
BackgroundC monotherapy is approved for pts with ABC who progress after anthracycline (A) and taxane (T) therapies. SU is an oral, multitargeted tyrosine kinase inhibitor that has demonstrated a single-agent response rate of 11% in heavily pretreated
Autor:
Marla J. Brickman, Andrew E. Balber
Publikováno v:
The Journal of protozoology. 37(3)
Specific binding of fluoresceinated succinyl-concanavalin A, wheat germ agglutinin, and ricin to untreated and trypsinized bloodstream forms of Trypanosoma brucei rhodesiense was quantitated by flow cytofluorimetry, and sites of lectin binding were i